| Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation L Shan, K Deng, NS Shroff, CM Durand, SA Rabi, HC Yang, H Zhang, ... Immunity 36 (3), 491-501, 2012 | 846 | 2012 |
| Follicular CXCR5-expressing CD8+ T cells curtail chronic viral infection R He, S Hou, C Liu, A Zhang, Q Bai, M Han, Y Yang, G Wei, T Shen, ... Nature 537 (7620), 412-416, 2016 | 599 | 2016 |
| Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations K Deng, M Pertea, A Rongvaux, L Wang, CM Durand, G Ghiaur, J Lai, ... Nature 517 (7534), 381-385, 2015 | 572 | 2015 |
| CRISPR-edited stem cells in a patient with HIV and acute lymphocytic leukemia L Xu, J Wang, Y Liu, L Xie, B Su, D Mou, L Wang, T Liu, X Wang, B Zhang, ... New England Journal of Medicine 381 (13), 1240-1247, 2019 | 412 | 2019 |
| Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor X Chen, R Li, Z Pan, C Qian, Y Yang, R You, J Zhao, P Liu, L Gao, Z Li, ... Cellular & molecular immunology 17 (6), 647-649, 2020 | 362 | 2020 |
| Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19 X Chen, Z Pan, S Yue, F Yu, J Zhang, Y Yang, R Li, B Liu, X Yang, L Gao, ... Signal transduction and targeted therapy 5 (1), 180, 2020 | 261 | 2020 |
| Transcriptional Reprogramming during Effector-to-Memory Transition Renders CD4+ T Cells Permissive for Latent HIV-1 Infection L Shan, K Deng, H Gao, S Xing, AA Capoferri, CM Durand, SA Rabi, ... Immunity 47 (4), 766-775. e3, 2017 | 195 | 2017 |
| TRIM28 promotes HIV-1 latency by SUMOylating CDK9 and inhibiting P-TEFb X Ma, T Yang, Y Luo, L Wu, Y Jiang, Z Song, T Pan, B Liu, G Liu, J Liu, ... eLife 8, e42426, 2019 | 86 | 2019 |
| Efficient Production of Mice from Embryonic Stem Cells Injected into Four‐or Eight‐Cell Embryos by Piezo Micromanipulation J Huang, K Deng, H Wu, Z Liu, Z Chen, S Cao, L Zhou, X Ye, DL Keefe, ... Stem cells 26 (7), 1883-1890, 2008 | 66 | 2008 |
| Two waves of pro-inflammatory factors are released during the influenza A virus (IAV)-driven pulmonary immunopathogenesis J Zhang, J Liu, Y Yuan, F Huang, R Ma, B Luo, Z Xi, T Pan, B Liu, Y Zhang, ... PLoS pathogens 16 (2), e1008334, 2020 | 48 | 2020 |
| Imatinib and methazolamide ameliorate COVID-19-induced metabolic complications via elevating ACE2 enzymatic activity and inhibiting viral entry Z Li, M Peng, P Chen, C Liu, A Hu, Y Zhang, J Peng, J Liu, Y Li, W Li, ... Cell Metabolism 34 (3), 424-440. e7, 2022 | 40 | 2022 |
| Intravenous injection of the oncolytic virus M1 awakens antitumor T cells and overcomes resistance to checkpoint blockade Y Liu, J Cai, W Liu, Y Lin, L Guo, X Liu, Z Qin, C Xu, Y Zhang, X Su, ... Cell Death & Disease 11 (12), 1062, 2020 | 37 | 2020 |
| Early treatment may not be early enough K Deng, RF Siliciano Nature 512 (7512), 35-36, 2014 | 29 | 2014 |
| CD161+ CD4+ T Cells Harbor Clonally Expanded Replication-Competent HIV-1 in Antiretroviral Therapy-Suppressed Individuals X Li, Z Liu, Q Li, R Hu, L Zhao, Y Yang, J Zhao, Z Huang, H Gao, L Li, ... mBio 10 (5), e02121-19, 2019 | 21 | 2019 |
| USP49 potently stabilizes APOBEC3G protein by removing ubiquitin and inhibits HIV-1 replication T Pan, Z Song, L Wu, G Liu, X Ma, Z Peng, M Zhou, L Liang, B Liu, J Liu, ... Elife 8, e48318, 2019 | 21 | 2019 |
| 35B5 antibody potently neutralizes SARS-CoV-2 Omicron by disrupting the N-glycan switch via a conserved spike epitope X Wang, X Chen, J Tan, S Yue, R Zhou, Y Xu, Y Lin, Y Yang, Y Zhou, ... Cell host & microbe 30 (6), 887-895. e4, 2022 | 19 | 2022 |
| A bivalent nanoparticle vaccine exhibits potent cross-protection against the variants of SARS-CoV-2 Y Yuan, X Zhang, R Chen, Y Li, B Wu, R Li, F Zou, X Ma, X Wang, Q Chen, ... Cell Reports 38 (3), 2022 | 19 | 2022 |
| A potent human monoclonal antibody with pan-neutralizing activities directly dislocates S trimer of SARS-CoV-2 through binding both up and down forms of RBD X Wang, A Hu, X Chen, Y Zhang, F Yu, S Yue, A Li, J Zhang, Z Pan, ... Signal Transduction and Targeted Therapy 7 (1), 114, 2022 | 18 | 2022 |
| Glycopeptide antibiotic teicoplanin inhibits cell entry of SARS-CoV-2 by suppressing the proteolytic activity of cathepsin L F Yu, T Pan, F Huang, R Ying, J Liu, H Fan, J Zhang, W Liu, Y Lin, Y Yuan, ... Frontiers in Microbiology 13, 884034, 2022 | 17 | 2022 |
| Lovastatin inhibits HIV-1-induced MHC-I downregulation by targeting Nef–AP-1 complex formation: A new strategy to boost immune eradication of HIV-1 infected cells B Liu, X Zhang, W Zhang, L Wu, S Jing, W Liu, B Xia, F Zou, L Lu, X Ma, ... Frontiers in immunology 10, 2151, 2019 | 16 | 2019 |
Robert F. SilicianoProfessor of Medicine, Johns Hopkins University School of MedicineVerified email at jhmi.edu
